National Health Investors
244 hedge funds and large institutions have $2.06B invested in National Health Investors in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 87 increasing their positions, 82 reducing their positions, and 24 closing their positions.
67% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 24
14% more capital invested
Capital invested by funds: $1.81B → $2.06B (+$251M)
7% more funds holding
Funds holding: 229 → 244 (+15)
6% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 82
1% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $3.94M
0.55% less ownership
Funds ownership: 67.26% → 66.71% (-0.55%)
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$24.9M |
| 2 |
BlackRock
New York
|
+$17M |
| 3 |
WCP
Waterfront Capital Partners
New York
|
+$12.7M |
| 4 |
JP Morgan Chase
New York
|
+$10.1M |
| 5 |
Two Sigma Advisers
New York
|
+$5.64M |
Top Sellers
NHI Hedge Fund Activity: Q4 2020 in Review
244 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in National Health Investors (NHI) for Q4 2020, worth a combined $2.06B — up 14% from $1.81B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new NHI positions and 24 closed out — a net gain of 16 holders — while 87 added to existing stakes and 82 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $24.9M. The largest seller was Hamlin Capital Management, exiting entirely with an estimated $56M sold.
- 244 institutional investors held National Health Investors (NHI) as of Q4 2020, up from 229 in Q3 2020.
- Funds reported $2.06B of National Health Investors stock for Q4 2020, up 14% quarter-over-quarter.
- 40 funds opened new National Health Investors positions in Q4 2020 and 24 closed out, a net change of +16 holders.
- The largest National Health Investors buyer in Q4 2020 was Goldman Sachs, an estimated $24.9M added.
- The largest National Health Investors seller in Q4 2020 was Hamlin Capital Management, an estimated $56M sold.
Based on aggregated 13F filings for Q4 2020.